Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

Review

Rationale of using different biological therapies in rheumatoid arthritis

Matthias Geyer and Ulf Müller-Ladner*

Author Affiliations

Justus-Liebig-University of Giessen, Department of Rheumatology and Clinical Immunology, Kerckhoff-Klinik, Benekestr. 2-8, D-61231 Bad Nauheim, Germany

For all author emails, please log on.

Arthritis Research & Therapy 2010, 12:214  doi:10.1186/ar3102

Published: 24 August 2010

Abstract

Due to ongoing developments of novel agents in the field of biological pharmacotherapy, there are now more arrows available in clinicians' quivers for the treatment of rheumatic conditions. As a consequence, however, clear treatment strategies have to be defined in order to guarantee a qualitatively high and individually stage-adapted, state-of-the-art regimen for affected patients. This review summarizes recent evidence regarding the rationale of using different biological therapies to treat rheumatoid arthritis, the most common inflammatory joint disorder after activated osteoarthritis, and draws an actual picture of a possible standardized therapeutic algorithm without claiming exclusive appropriateness.